Literature DB >> 35296451

Intertwined pathways of complement activation command the pathogenesis of lupus nephritis.

Abhigyan Satyam1, Ryo Hisada2, Rhea Bhargava2, Maria G Tsokos2, George C Tsokos2.   

Abstract

The complement system is involved in the origin of autoimmunity and systemic lupus erythematosus. Both genetic deficiency of complement components and excessive activation are involved in primary and secondary renal diseases, including lupus nephritis. Among the pathways, the classical pathway has long been accepted as the main pathway of complement activation in systemic lupus erythematosus. However, more recent studies have shown the contribution of factors B and D which implies the involvement of the alternative pathway. While there is evidence on the role of the lectin pathway in systemic lupus erythematosus, it is yet to be demonstrated whether this pathway is protective or harmful in lupus nephritis. Complement is being explored for the development of disease biomarkers and therapeutic targeting. In the current review we discuss the involvement of complement in lupus nephritis.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35296451      PMCID: PMC9167748          DOI: 10.1016/j.trsl.2022.03.005

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   10.171


  124 in total

1.  Complement-mediated thrombotic microangiopathy associated with lupus nephritis.

Authors:  Mi Hee Park; Nicholas Caselman; Scott Ulmer; Ilene Ceil Weitz
Journal:  Blood Adv       Date:  2018-08-28

Review 2.  CR1 and CR1-like: the primate immune adherence receptors.

Authors:  D J Birmingham; L A Hebert
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

3.  The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Authors:  Peter Hillmen; Neal S Young; Jörg Schubert; Robert A Brodsky; Gerard Socié; Petra Muus; Alexander Röth; Jeffrey Szer; Modupe O Elebute; Ryotaro Nakamura; Paul Browne; Antonio M Risitano; Anita Hill; Hubert Schrezenmeier; Chieh-Lin Fu; Jaroslaw Maciejewski; Scott A Rollins; Christopher F Mojcik; Russell P Rother; Lucio Luzzatto
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

Review 4.  Complement deficiency states and associated infections.

Authors:  Lillemor Skattum; Marcel van Deuren; Tom van der Poll; Lennart Truedsson
Journal:  Mol Immunol       Date:  2011-05-31       Impact factor: 4.407

5.  BAFF Induces Tertiary Lymphoid Structures and Positions T Cells within the Glomeruli during Lupus Nephritis.

Authors:  SunAh Kang; Yuri Fedoriw; Ethan K Brenneman; Young K Truong; Kristine Kikly; Barbara J Vilen
Journal:  J Immunol       Date:  2017-02-24       Impact factor: 5.422

Review 6.  Complement in immune and inflammatory disorders: pathophysiological mechanisms.

Authors:  Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

7.  Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility.

Authors:  Jian Zhao; Hui Wu; Melanie Khosravi; Huijuan Cui; Xiaoxia Qian; Jennifer A Kelly; Kenneth M Kaufman; Carl D Langefeld; Adrienne H Williams; Mary E Comeau; Julie T Ziegler; Miranda C Marion; Adam Adler; Stuart B Glenn; Marta E Alarcón-Riquelme; Bernardo A Pons-Estel; John B Harley; Sang-Cheol Bae; So-Young Bang; Soo-Kyung Cho; Chaim O Jacob; Timothy J Vyse; Timothy B Niewold; Patrick M Gaffney; Kathy L Moser; Robert P Kimberly; Jeffrey C Edberg; Elizabeth E Brown; Graciela S Alarcon; Michelle A Petri; Rosalind Ramsey-Goldman; Luis M Vilá; John D Reveille; Judith A James; Gary S Gilkeson; Diane L Kamen; Barry I Freedman; Juan-Manuel Anaya; Joan T Merrill; Lindsey A Criswell; R Hal Scofield; Anne M Stevens; Joel M Guthridge; Deh-Ming Chang; Yeong Wook Song; Ji Ah Park; Eun Young Lee; Susan A Boackle; Jennifer M Grossman; Bevra H Hahn; Timothy H J Goodship; Rita M Cantor; Chack-Yung Yu; Nan Shen; Betty P Tsao
Journal:  PLoS Genet       Date:  2011-05-26       Impact factor: 5.917

Review 8.  Molecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"?

Authors:  Miriam D Neher; Sebastian Weckbach; Michael A Flierl; Markus S Huber-Lang; Philip F Stahel
Journal:  J Biomed Sci       Date:  2011-11-30       Impact factor: 8.410

9.  Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.

Authors:  Anna Schubart; Karen Anderson; Nello Mainolfi; Holger Sellner; Takeru Ehara; Christopher M Adams; Aengus Mac Sweeney; Sha-Mei Liao; Maura Crowley; Amanda Littlewood-Evans; Sophie Sarret; Grazyna Wieczorek; Ludovic Perrot; Valérie Dubost; Thierry Flandre; Yuzhou Zhang; Richard J H Smith; Antonio M Risitano; Rajeshri G Karki; Chun Zhang; Eric Valeur; Finton Sirockin; Bernd Gerhartz; Paulus Erbel; Nicola Hughes; Thomas M Smith; Frederic Cumin; Upendra A Argikar; Börje Haraldsson; Muneto Mogi; Richard Sedrani; Christian Wiesmann; Bruce Jaffee; Jürgen Maibaum; Stefanie Flohr; Richard Harrison; Jörg Eder
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-29       Impact factor: 11.205

10.  Curb complement to cure COVID-19.

Authors:  Abhigyan Satyam; George C Tsokos
Journal:  Clin Immunol       Date:  2020-10-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.